New AAP Guidance: Exome and genome sequencing recommended as first-line tests. Learn more

Provider Portal

Don't tell me my symptoms don't add up. One test can change everything. Diagnosis is Power.

Don't tell me my symptoms don't add up. One test can change everything. Diagnosis is Power.

New AAP guidance. Exome and genome sequencing recommended as first-line tests.

New genes linked
to ASD

230 more genes recently linked to autism highlight the importance of genetic testing for co-occurring conditions.

Ordering genome sequencing for more critically ill babies in the NICU finds more answers.

ultraRapid Genome available now

Results as soon as 2 days.
Because every moment matters.

Genome sequencing for infant in the NICU

60% of level IV NICU infants could benefit from rapid genome

New study shows that nearly 42% of diagnosed infants would have been missed under current NICU protocols.

Elevate patient care
with our Epic Aura
integration

Seamlessly integrate the power of GeneDx testing into your Epic Aura EHR.

When a cerebral palsy diagnosis isn’t diagnosis enough

Ashley refused to accept a broad cerebral palsy diagnosis and pushed for a precise genetic diagnosis for her daughter—preventing permanent nerve damage and vision loss.

Read their story

We’re in the business of accelerating diagnosis.

We see a future where any genetic disorder is diagnosed quickly to prevent disease progression and ensure long and healthy lives for all.

The key? Exome and genome sequencing.

Exome and genome are no longer specialized tests.
They’re the standard of care.

Recommended by guidelines as a first-line test. More likely to deliver a diagnosis.
The time for exome and genome is now.

For your patients in the NICU

For your patients with developmental disorders

For your patients with unexplained epilepsy

For your patients with cerebral palsy

For your patients with autism

Not a healthcare provider?
Learn more about testing here.

Reach a diagnosis faster with
the most comprehensive genetic tests.

Exome sequencing
delivers 2x the diagnostic yield of chromosomal microarray (CMA) and multigene panels.^1,2

Genome sequencing
is the most comprehensive genetic test available and includes mitochondrial genome sequencing.

Rapid genome sequencing
can help identify the 1 in 3 infants in the intensive care unit that likely have a genetic disorder.³

GenomeXpress^®

Move forward with confidence.
Move forward with GeneDx.

Ready to talk in more detail? Schedule a call today.

Connect with a rep

Broad testing, precise answers

With advanced genomic technologies, our unmatched internal database, and extensive clinical expertise, GeneDx’s industry-leading tests deliver clinically actionable results, faster.

The GeneDx difference: Accurate. Actionable. Accessible.

There’s a reason we’re the go-to lab when providers need diagnoses for children with both rare diseases and common conditions. It includes comprehensive, actionable results, unparalleled support, and a genuine dedication to putting patients first.

In the news

References: 1. Savatt JM, Myers SM. Front Pediatr. 2021 Feb 19;9:526779. doi: 10.3389/fped.2021.52679. 2. Srivastava S, Love-Nichols JA, Dies KA, et al. Genet Med. 2019 Nov;21(11):2413–2421; https://doi.org/10.1038/s41436-019-0554-6. 3. Wenger T, Scott A, Kruidenier L, et al. AM J Hum Genet. 2025; 112, 1-15.